"Resurrection of thrombin" in the pathophysiology of the antiphospholipid syndrome

Arthritis and Rheumatism

Volumn 56, Issue 2, 2007, Pages 393-394

  Koike, Takao ^a   Atsumi, Tatsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; PROTHROMBIN; THROMBIN;

AMINO ACID SEQUENCE; ANTIPHOSPHOLIPID SYNDROME; BINDING SITE; BLOOD CLOTTING; CELL ACTIVATION; CONSENSUS SEQUENCE; EDITORIAL; ENZYME ACTIVITY; HUMAN; MOLECULAR SIZE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; HUMANS; PROTEIN BINDING; PROTHROMBIN; THROMBIN;

EID: 33847077201     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22366     Document Type: Editorial

References (15)

1. Khamashta MA. Hughes syndrome: history. In: Khamashta MA, editor. Hughes syndrome: antiphospholipid syndrome. 2nd ed. London: Springer-Verlag; 2006. p. 3-8.
2. Schultze HE, Heide K, Haput H. Uber ein bisher ubekanntes niedermolekulars β2-Globulin des Humanserums. Naturwissenschaften 1961;48:719.
3. Lozier J, Takahashi N, Putnam FW. Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci U S A 1984;81:3640-4.
4. 2-glycoprotein I to phospholipids based on its crystal structure. EMBO J 1999;18:5166-74.
5. Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM, Laggner P, et al. Crystal structure of human β2-grycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 1999;18:6228-39.
6. 2 glycoprotein I antibodies. Int Immunol 2004;16:1633-41.
7. Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005;52:1545-54.
8. Lopez-Pedrera C, Buendia P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N, et al. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum 2006;54:301-11.
9. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood 2005;105:1964-9.
10. Pennings MT, van Lummel M, Derksen RH, Urbanus RT, Romijn RA, Lenting PJ, et al. Interaction of β2-glycoprotein I with members of the low density lipoprotein receptor family. J Thromb Haemost 2006;4:1680-90.
11. Sheng Y, Reddel SW, Herzog H, Wang YX, Brighton T, France MP, et al. Impaired thrombin generation in β2-glycoprotein I null mice. J Biol Chem 2001;276:13817-21.
12. Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, et al. β 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped β 2-glycoprotein I. Proc Natl Acad Sci U S A 2004;101:3939-44.
13. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005;3:1861-72.
14. 2-glycoprotein I on thrombin-mediated factor XIa generation. Arthritis Rheum 2007;56:605-613.
15. 2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 1999; 42:167-74.